SCHEMBL13288262

SCHEMBL13288262

[C-]#[N+]c1cc(C)c(Br)c(C)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10053219 0.73 ALDH1A1 (0.37) —
SCHEMBL12400058 0.70 ALDH1A1 (0.36) —
SCHEMBL999206 0.69 ALDH1A1 (0.40) —
SCHEMBL13312950 0.69 ALDH1A1 (0.33) —
SCHEMBL9289476 0.69 CYP3A4 (0.50) —
SCHEMBL12383641 0.69 ALDH1A1 (0.37) —
SCHEMBL29953344 0.68 KDM1A (0.35) —
SCHEMBL29353234 0.68 ALDH1A1 (0.40) —
SCHEMBL6065091 0.68 ALDH1A1 (0.40) —
SCHEMBL156826 0.67 RAPGEF4 (0.45) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180062084-A1 Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Organometallic Complex SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2018-03-01 — — US disclosed
US-20160372688-A1 IRIDIUM COMPLEX, LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-12-22 — — US disclosed
US-20160257652-A1 ANTIDIABETIC TRICYCLIC COMPOUNDS MERCK SHARP & DOHME CORP. 2016-09-08 — — US disclosed
US-9187408-B2 Process for the preparation of protected L-alanine derivatives JANSSEN PHARMACEUTICA NV (BE) 2015-11-17 — — US disclosed
US-20140378701-A1 PROCESS FOR THE PREPARATION OF PROTECTED L-ALANINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2014-12-25 — — US disclosed
US-8853445-B2 Process for the preparation of protected L-alanine derivatives JANSSEN PHARMACEUTICA, N.V. (BE) 2014-10-07 — — US disclosed
US-20140135525-A1 PROCESS FOR THE PREPARATION OF PROTECTED L-ALANINE DERIVATIVES JANSSEN PHARMACEUTICA, N.V. (BE) 2014-05-15 — — US disclosed
US-8710256-B2 Process for the preparation of protected L-alanine derivatives JANSSEN PHARMACEUTICA, N.V. (BE) 2014-04-29 — — US disclosed
US-20100145090-A1 PROCESS FOR THE PREPARATION OF PROTECTED L ALANINE DERIVATIVES JANSSEN PHARMACEUTICA, N.V. (BE) 2010-06-10 — — US disclosed
Send feedback